AnPac Bio-Medical Science Co., Ltd.
(NASDAQ : ANPC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 8.73%147.660.0%$994.17m
AMGNAmgen, Inc. 0.87%255.261.5%$856.48m
GILDGilead Sciences, Inc. 0.51%64.801.0%$543.24m
VRTXVertex Pharmaceuticals, Inc. 1.51%273.731.9%$497.98m
REGNRegeneron Pharmaceuticals, Inc. 1.37%692.802.6%$444.80m
ILMNIllumina, Inc. 5.95%258.063.3%$337.13m
NVAXNovavax, Inc. 17.46%55.2975.7%$314.14m
BIIBBiogen, Inc. 0.97%206.201.8%$237.64m
BNTXBioNTech SE 5.57%166.960.0%$224.59m
SNSSSunesis Pharmaceuticals, Inc. 2.38%2.150.7%$150.29m
EXASEXACT Sciences Corp. 7.96%53.8317.7%$134.25m
TECHBio-Techne Corp. 5.81%386.564.5%$107.96m
TXG10X Genomics, Inc. 11.91%52.990.0%$106.79m
BMRNBioMarin Pharmaceutical, Inc. 2.68%80.974.2%$95.42m
CRSPCRISPR Therapeutics AG 5.63%58.340.6%$85.42m

Company Profile

Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.